-
SGMO Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Sangamo Therapeutics (SGMO)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 40.70 mm | 40.70 mm | 40.70 mm | 40.70 mm | 40.70 mm | 40.70 mm |
Cash burn (monthly) | (no burn) | 1.44 mm | (no burn) | 11.66 mm | (no burn) | 9.53 mm |
Cash used (since last report) | n/a | 5.92 mm | n/a | 47.85 mm | n/a | 39.10 mm |
Cash remaining | n/a | 34.78 mm | n/a | -7.15 mm | n/a | 1.60 mm |
Runway (months of cash) | n/a | 24.1 | n/a | -0.6 | n/a | 0.2 |
13F holders | Current |
---|---|
Total holders | 105 |
Opened positions | 16 |
Closed positions | 40 |
Increased positions | 23 |
Reduced positions | 36 |
13F shares | Current |
---|---|
Total value | 47.64 bn |
Total shares | 59.18 mm |
Total puts | 1.17 mm |
Total calls | 575.50 k |
Total put/call ratio | 2.0 |
Largest owners | Shares | Value |
---|---|---|
Wasatch Advisors | 19.44 mm | $16.84 bn |
Vanguard | 9.60 mm | $8.31 bn |
Renaissance Technologies | 4.85 mm | $4.20 bn |
BlackRock | 3.63 mm | $3.14 bn |
BIIB Biogen | 3.25 mm | $2.96 mm |
Marshall Wace | 2.35 mm | $2.05 bn |
Geode Capital Management | 2.14 mm | $1.85 bn |
Millennium Management | 1.91 mm | $1.66 bn |
Jacobs Levy Equity Management | 1.47 mm | $1.27 bn |
Charles Schwab Investment Management | 1.10 mm | $955.59 mm |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
22 Jan 25 | Gregory D Davis | Common Stock | Payment of exercise | Dispose F | No | No | 1.15 | 30,456 | 35.02 k | 167,570 |
22 Jan 25 | Nathalie Dubois-Stringfellow | Common Stock | Payment of exercise | Dispose F | No | No | 1.15 | 129,593 | 149.03 k | 716,710 |
22 Jan 25 | Scott B. Willoughby | Common Stock | Payment of exercise | Dispose F | No | No | 1.15 | 129,549 | 148.98 k | 697,651 |
22 Jan 25 | Duraibabu Prathyusha | Common Stock | Payment of exercise | Dispose F | No | No | 1.15 | 129,242 | 148.63 k | 694,970 |
22 Jan 25 | Sandy Macrae | Common Stock | Payment of exercise | Dispose F | No | No | 1.15 | 412,584 | 474.47 k | 2,095,999 |